tiprankstipranks
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
US Market
PMCB
PharmaCyte Biotech
RESEARCH TOOLSreports

PharmaCyte Biotech (PMCB) Financial Statements

263 Followers

PharmaCyte Biotech Financial Overview

PharmaCyte Biotech's market cap is currently $6.44M. The company's EPS TTM is $; its P/E ratio is -0.55; PharmaCyte Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 26Apr 25Apr 24Apr 23Apr 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -5.30M$ -4.38M$ -6.52M$ -6.46M$ -4.39M
EBITDA$ -6.85T$ 30.66M$ 6.85M$ -4.32M$ -4.24M
Net Income$ -19.42M$ 30.66M$ 333.76K$ -4.32M$ -4.24M
Balance Sheet
Cash & Short-Term Investments$ 37.08M$ 15.54M$ 50.18M$ 68.04M$ 85.40M
Total Assets$ 46.75M$ 55.17M$ 59.90M$ 73.28M$ 90.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -18.60M$ -15.17M$ -50.18M$ -68.04M$ -85.40M
Total Liabilities$ 11.77M$ 3.28M$ 20.39M$ 586.58K$ 704.37K
Stockholders' Equity$ 34.56M$ 51.89M$ 39.51M$ 72.69M$ 89.92M
Cash Flow
Free Cash Flow$ -5.15T$ -2.98M$ -2.15M$ -3.79M$ -4.12M
Operating Cash Flow$ -5.15T$ -2.98M$ -2.15M$ -3.79M$ -4.12M
Investing Cash Flow$ 2.00T$ -7.00M$ -5.00M$ 0.00$ 0.00
Financing Cash Flow$ 6.58T$ -25.03M$ -10.71M$ -13.56M$ 87.31M
Currency in USD

PharmaCyte Biotech Earnings and Revenue History

Income Statement >

PharmaCyte Biotech Debt to Assets

Balance Sheet >

PharmaCyte Biotech Cash Flow

Cash Flow >

PharmaCyte Biotech Forecast EPS vs Actual EPS

Earnings >